Medical therapies for hypertrophic cardiomyopathy: Current state of the art
Progress in Cardiovascular Diseases · 2023-09 · 80 · 32-37
DOI: 10.1016/j.pcad.2023.08.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Progress in Cardiovascular Diseases, 2023-09. Verfasst von Milind Y Desai und 2 weiteren Autor:innen. Beteiligte Einrichtung: From the Hypertrophic Cardiomyopathy Center, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH, United States of Amer…. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Heart Failure, Heart Transplantation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- From the Hypertrophic Cardiomyopathy Center, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH, United States of America; Center for Inherited Cardiovascular Disease, Department of Cardio…
Zitieren
APA
Desai, M. Y., Owens, A., & Wang, A. (2023). Medical therapies for hypertrophic cardiomyopathy: Current state of the art. Progress in Cardiovascular Diseases, 80, 32-37. https://doi.org/10.1016/j.pcad.2023.08.006
Vancouver
Desai MY, Owens A, Wang A. Medical therapies for hypertrophic cardiomyopathy: Current state of the art. Progress in Cardiovascular Diseases. 2023;80:32-37. doi:10.1016/j.pcad.2023.08.006
BibTeX
@article{Desai2023,
author = {Desai, Milind Y and Owens, Anjali and Wang, Andrew},
title = {Medical therapies for hypertrophic cardiomyopathy: Current state of the art},
journal = {Progress in Cardiovascular Diseases},
year = {2023},
volume = {80},
pages = {32--37},
doi = {10.1016/j.pcad.2023.08.006}
}
EUVIMED